Can a freezing balloon beat drugs for persistent AF?
NCT ID NCT04942834
First seen Aug 18, 2026 · Last updated Aug 18, 2026
Summary
This trial tests whether using cryoballoon ablation as the first treatment for persistent atrial fibrillation (AF) is more effective and safer than starting with anti-arrhythmic drugs. Adults aged 18-75 with symptomatic persistent AF and a structurally normal heart are eligible. Participants are randomly assigned to receive either cryoballoon ablation or drug therapy, and the study tracks freedom from AF recurrence and quality of life over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cryoballoon ablation (a procedure using a balloon cooled to freeze heart tissue) compared with anti-arrhythmic drugs (propafenone, sotalol, dronedarone, amiodarone)
- What this could lead to
- If cryoballoon ablation works better than drugs as a first treatment, it could become a preferred option for persistent AF, potentially reducing the need for long-term medication and improving quality of life.
- What could go wrong
- This is a single-center trial, and results may not apply to all patients. Ablation carries risks like bleeding, infection, or heart damage, and AF may still return.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARRHYTHMIAS, CARDIAC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
"West China School of Medicine /West China Hospital of Sichuan University "
Chengdu, Sichuan, 610041, China
-
Affiliated Hospital Of Nantong University
Nantong, Jiangsu, 226019, China
-
Dongguan People's Hospital
Dongguan, Guangdong, 523018, China
-
Fujian Provincial Hospital
Fuzhou, Fujian, 350001, China
-
Jiangsu Taizhou People's Hospital
Taizhou, Jiangsu, 225300, China
-
Nanjing Drum Tower hospital
Nanjing, Jiangsu, 210008, China
-
Qilu Hospital Of Shandong University
Jinan, Shangdong, 250012, China
-
Ruijin Hospital
Shanghai, Shanghai Municipality, 200025, China
-
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, 200072, China
-
Sun Yat-sen Memorial Hospital
Guangzhou, Guangdong, 510120, China
-
The Affiliated Hospital Of Guizhou Medical University
Guiyang, Guizhou, 561113, China
-
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, 830054, China
-
The First Affiliated Hospital,Sun Yat-sen University
Guangzhou, Guangdong, 511466, China
-
The Second Hospital Of Tianjin Medical University
Tianjin, Tianjin Municipality, 300211, China
-
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, 300022, China
-
Xuzhou Central Hospital
Xuzhou, Jiangsu, 221009, China
-
Zhongda Hospital Southeast University
Nanjing, Jiangsu, 210009, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a dual energy catheter tame dangerous heart rhythms?
- Single-Lead ICD that spots hidden heart rhythm problems
- AI maps the way to better heart ablation?
- New Dual-Action heart procedure could tame stubborn AFib
- Heat wave warning: study reveals how chronic illness patients suffer in high temperatures
- New heart device aims to stop deadly rhythms in heart failure patients